Equitable Trust Co. Has $1.42 Million Holdings in Danaher Corporation $DHR

Equitable Trust Co. trimmed its holdings in shares of Danaher Corporation (NYSE:DHR) by 41.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,140 shares of the conglomerate’s stock after selling 5,110 shares during the quarter. Equitable Trust Co.’s holdings in Danaher were worth $1,416,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of DHR. Catawba River Capital raised its position in shares of Danaher by 1.4% in the third quarter. Catawba River Capital now owns 40,067 shares of the conglomerate’s stock valued at $7,944,000 after buying an additional 551 shares in the last quarter. Avalon Trust Co raised its holdings in Danaher by 5.1% in the 3rd quarter. Avalon Trust Co now owns 78,807 shares of the conglomerate’s stock valued at $15,624,000 after acquiring an additional 3,847 shares in the last quarter. Koshinski Asset Management Inc. lifted its position in shares of Danaher by 11.9% during the 3rd quarter. Koshinski Asset Management Inc. now owns 2,285 shares of the conglomerate’s stock valued at $453,000 after acquiring an additional 243 shares during the period. Zeno Equity Partners LLP grew its holdings in shares of Danaher by 2.6% during the 3rd quarter. Zeno Equity Partners LLP now owns 265,795 shares of the conglomerate’s stock worth $52,756,000 after purchasing an additional 6,856 shares in the last quarter. Finally, Ellerson Group Inc. ADV increased its position in shares of Danaher by 0.8% in the third quarter. Ellerson Group Inc. ADV now owns 14,292 shares of the conglomerate’s stock worth $2,834,000 after purchasing an additional 107 shares during the period. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on DHR. Morgan Stanley assumed coverage on shares of Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 price objective for the company. Argus set a $265.00 price target on shares of Danaher in a report on Wednesday, January 14th. HSBC lifted their price objective on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research note on Monday, December 1st. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a report on Thursday, January 29th. Twenty investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $253.86.

Insider Activity

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 11.20% of the stock is owned by corporate insiders.

Danaher Stock Performance

Shares of Danaher stock opened at $210.90 on Tuesday. The company’s 50 day moving average price is $226.49 and its two-hundred day moving average price is $216.12. The firm has a market capitalization of $148.97 billion, a P/E ratio of 41.84, a P/E/G ratio of 2.83 and a beta of 0.91. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The company had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company earned $2.14 EPS. On average, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s payout ratio is 25.40%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.